Chloral hydrate toxicity in a preterm infant

A. R. Laptook, C. R. Rosenfeld

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Ventilator care in premature infants with hyaline membrane disease (HMD) may be complicated by episodes of irritability and 'fighting' the respirator, resulting in significant hypoxemia. Neuromuscular blockade with pharmacologic agents such as pancuronium bromide is frequently used to manage this problem [Crone and Favorito, 1980]. This therapy results in the loss of important clinical signs, such as alterations in muscle tone and spontaneous movements, which are important in monitoring the critically ill newborn. As a result of these considerations, we occasionally have utilized the sedative-hypnotic effects of chloral hydrate to achieve adequate ventilation and oxygenation in these infants. We report, however, a case of a preterm infant who developed severe chloral hydrate toxicity after its administration as an adjunct to the treatment of HMD.

Original languageEnglish (US)
Pages (from-to)161-165
Number of pages5
JournalPediatric Pharmacology
Volume4
Issue number3
StatePublished - 1984

Fingerprint

Hyaline Membrane Disease
Chloral Hydrate
Mechanical Ventilators
Hypnotics and Sedatives
Premature Infants
Pancuronium
Neuromuscular Blockade
Critical Illness
Ventilation
Newborn Infant
Muscles
Therapeutics
Hypoxia

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Chloral hydrate toxicity in a preterm infant. / Laptook, A. R.; Rosenfeld, C. R.

In: Pediatric Pharmacology, Vol. 4, No. 3, 1984, p. 161-165.

Research output: Contribution to journalArticle

Laptook, A. R. ; Rosenfeld, C. R. / Chloral hydrate toxicity in a preterm infant. In: Pediatric Pharmacology. 1984 ; Vol. 4, No. 3. pp. 161-165.
@article{5c28e2d4276240a8b2d11f2e78bbe4d2,
title = "Chloral hydrate toxicity in a preterm infant",
abstract = "Ventilator care in premature infants with hyaline membrane disease (HMD) may be complicated by episodes of irritability and 'fighting' the respirator, resulting in significant hypoxemia. Neuromuscular blockade with pharmacologic agents such as pancuronium bromide is frequently used to manage this problem [Crone and Favorito, 1980]. This therapy results in the loss of important clinical signs, such as alterations in muscle tone and spontaneous movements, which are important in monitoring the critically ill newborn. As a result of these considerations, we occasionally have utilized the sedative-hypnotic effects of chloral hydrate to achieve adequate ventilation and oxygenation in these infants. We report, however, a case of a preterm infant who developed severe chloral hydrate toxicity after its administration as an adjunct to the treatment of HMD.",
author = "Laptook, {A. R.} and Rosenfeld, {C. R.}",
year = "1984",
language = "English (US)",
volume = "4",
pages = "161--165",
journal = "Pediatric Pharmacology",
issn = "0270-322X",
number = "3",

}

TY - JOUR

T1 - Chloral hydrate toxicity in a preterm infant

AU - Laptook, A. R.

AU - Rosenfeld, C. R.

PY - 1984

Y1 - 1984

N2 - Ventilator care in premature infants with hyaline membrane disease (HMD) may be complicated by episodes of irritability and 'fighting' the respirator, resulting in significant hypoxemia. Neuromuscular blockade with pharmacologic agents such as pancuronium bromide is frequently used to manage this problem [Crone and Favorito, 1980]. This therapy results in the loss of important clinical signs, such as alterations in muscle tone and spontaneous movements, which are important in monitoring the critically ill newborn. As a result of these considerations, we occasionally have utilized the sedative-hypnotic effects of chloral hydrate to achieve adequate ventilation and oxygenation in these infants. We report, however, a case of a preterm infant who developed severe chloral hydrate toxicity after its administration as an adjunct to the treatment of HMD.

AB - Ventilator care in premature infants with hyaline membrane disease (HMD) may be complicated by episodes of irritability and 'fighting' the respirator, resulting in significant hypoxemia. Neuromuscular blockade with pharmacologic agents such as pancuronium bromide is frequently used to manage this problem [Crone and Favorito, 1980]. This therapy results in the loss of important clinical signs, such as alterations in muscle tone and spontaneous movements, which are important in monitoring the critically ill newborn. As a result of these considerations, we occasionally have utilized the sedative-hypnotic effects of chloral hydrate to achieve adequate ventilation and oxygenation in these infants. We report, however, a case of a preterm infant who developed severe chloral hydrate toxicity after its administration as an adjunct to the treatment of HMD.

UR - http://www.scopus.com/inward/record.url?scp=0021684611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021684611&partnerID=8YFLogxK

M3 - Article

C2 - 6493839

AN - SCOPUS:0021684611

VL - 4

SP - 161

EP - 165

JO - Pediatric Pharmacology

JF - Pediatric Pharmacology

SN - 0270-322X

IS - 3

ER -